asthma

Simple Green cleaners: Critics say it isn't green

U.S. Hospitals Get Better at Treating Heart Attacks, Pneumonia

U.S. hospitals are doing a more effective job treating patients for heart attacks, pneumonia and surgical procedures, an independent healthcare accreditation organization said in a report released today.

Merck Gets FDA Nod for Asthma Drug

Merck (MRK) today announced that the U.S. Food and Drug Administration has approved its respiratory drug Dulera for Asthma patients 12 years of age and older. Dulera is a new two-in-one, fixed-dose combination, which was developed by Schering-Plough and then inherited by Merck when it acquired its smaller rival last year.

Breathmobiles offer hope, free tests for kids with asthma